Log In

 

Company Name : Ferring Pharmaceuticals

Friday, March 17, 2017 9:25AM IST (3:55AM GMT)

(BW)(FERRING-PHARMACEUTICALS)

Ferring Pharmaceuticals: Waking up to Go to the Toilet is the Number One Cause of a Poor Night's Sleep, Say Experts on World Sleep Day


Saint-Prex, Switzerland

  • Nocturia, the need to wake up and urinate more than once at night, disturbs the sleep of 1 in 3 adults over the age of 30 and two thirds of adults over the age of 651
  • Up to 80% of people who complain of a disturbed night’s sleep report that nocturia is the main reason they wake in the middle of the night2
  • Nocturia may be a symptom of a serious health problem3
  • Poor sleep can put you at increased risk of cancer, diabetes and heart disease, as well as impacting productivity, relationships and careers4,5,6,7


On World Sleep Day sleep experts encourage people to understand the value of healthy and solid sleep. In particular, if they need to go to the toilet more than once in the night they have nocturia, a condition which affects one in three adults over the age of 30 and two thirds of adults over the age of 65.1

 

“People think that getting up in the night to go to the toilet is just part of getting older, but it doesn’t need to be,” says Philip Van Kerrebroeck, Editor of the Nocturia Resource Centre and Professor of Urology at the University of Maastricht. “Poor sleep can seriously damage your health so people who are getting up several times a night should go to their doctor to see what’s causing it. The good news is that nocturia can be treated so you don’t need to suffer in silence.”

 

The broken night’s sleep caused by trips to the bathroom can have huge consequences for mental and physical health. Productivity, relationships and career success can be impacted4. Lack of sleep can impact all forms of mental functioning, making it much harder to concentrate, remember things and pick up new skills or facts4.Poor sleep has also been linked to an increased risk of diabetes, weakened immune systems, heart disease and even some cancers5,6,7. Lack of sleep is also related to many psychological conditions such as depression, anxiety and psychosis8,9.

 

Nocturia, the need to wake up to pass urine at night, can be caused by an overproduction of urine3. It can also be caused by external factors such as: excess fluids before bedtime, medications, alcohol, caffeine, or diuretic medications; in rare cases it could also be a symptom of something more serious such as: diabetes, high blood pressure or cardiovascular disease3.

 

About Ferring Pharmaceuticals:
Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. To learn more about Ferring or its products please visit www.ferring.com.

 

About World Sleep Day
World Sleep Day is an annual event intended to be a celebration of sleep and a call to action on important issues related to sleep. It is organised by the World Sleep Day Committee of the World Sleep Society (founded by World Association of Sleep Medicine and the World Sleep Federation) and will take place on Friday 17th March 201710.

 

Ferring is a proud supporter of World Sleep Day

 

References

 

1 Bosch JL, Weiss JP. The prevalence and causes of nocturia. J Urol 2010 Aug; 184(2): 440-6. doi:10.1016/j.juro.2010.04.011.
2 Benefield LE. Facilitating Aging in Place: Safe, Sound, and Secure, An Issue of Nursing Clinics. 2014.
3 National Association for Continence website, Nocturia page. [Last Accessed January 2017] Available from: http://www.nafc.org/nocturia/
4 Orzel-Gryglewska, J. Consequences of Sleep Deprivation. International Journal of Occupational Medicine and Environmental Health 2010; 23(1): 95-114. doi:10.2478/v10001-010-0004-9.
5 Taheri S, Lin L, Austin D et al. Short sleep duration is associated with elevated ghrelin, reduced leptin and increased body mass index. PLoS Med 2004; 1(3): e62.
6 Gottlieb DJ, Punjabi NM, Newman AB et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005; 165(8): 863-7.
7 Meier-Ewert HK et al. Effect of Sleep Loss on C-Reactive Protein, an Inflammatory Marker of Cardiovascular Risk. Journal of the American College of Cardiology. 2004; 43(4). doi:10.1016/j.jacc.2003.07.050
8 Neckelmann D, Mykletun A, Dahl, AA. Chronic Insomnia as a Risk Factor for Developing Anxiety and Depression. Sleep 2007, 30(7): 873-880.
9 Petrovsky N et al. Sleep Deprivation Disrupts Prepulse Inhibition and Induces Psychosis-Like Symptoms in Healthy Humans. The Journal of Neuroscience 2014; July, 34(27)-913409140.
10 World Sleep Day website. Homepage. [Last accessed February 2017] Available at: www.worldsleepday.org

 

 

 

 


Click here for Media Contact Details
CONTACTS : Ferring PharmaceuticalsLindsey Rodger, +41 (0)584 514 023Lindsey.Rodger@Ferring.comorBurson-Marsteller for Ferring PharmaceuticalsJack Dixey, +44 (0)207 300 6221Jack.Dixey@bm.com

More News from Ferring Pharmaceuticals

28/11/2017 1:59AM

Ferring Receives Swiss Approval For Rekovelle®, The First Personalised Fertility Treatment Using an Approved Dosing Algorithm

Ferring Pharmaceuticals announced today that Swissmedic has approved Rekovelle® (follitropin delta) for use in controlled stimulation for induction of the development of multiple follicles in women undergoing ...

10/10/2017 8:05PM

Ferring Strengthens Growth Hormone Franchise Zomacton® Through Acquisition of ZomaJet™ Needle-Free Injector Device

Ferring Pharmaceuticals announced today that it has entered into a definitive agreement with Antares Pharma, Inc. to acquire the worldwide rights for the ZomaJet™ needle-free auto injector device.   This ...

03/10/2017 9:10AM

Ferring Appoints Klaus Dugi as Executive Vice President and Chief Medical Officer

Ferring Pharmaceuticals announced that Professor Klaus Dugi has been appointed Executive Vice President and Chief Medical Officer, effective immediately.   He will be responsible for Global Medical Affairs, ...

Similar News

11/12/2017 7:30PM

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017

2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External ...

No Image

11/12/2017 7:05PM

Valence Advises SK Capital on Its Acquisition of ICL's Fire Safety and Oil Additives Businesses

The Valence Group acted as lead financial advisor to SK Capital Partners on its announced acquisition of the Fire Safety and Oil Additives businesses of Israel Chemicals Ltd. (“ICL”) for approximately $1 ...